Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for MAFK
Z-value: 1.16
Motif logo
Transcription factors associated with MAFK
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MAFK
|
ENSG00000198517.5 | MAF bZIP transcription factor K |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MAFK | hg19_v2_chr7_+_1570322_1570360 | 0.29 | 1.2e-05 | Click! |
Activity profile of MAFK motif
Sorted Z-values of MAFK motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_-_89459813 | 34.31 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr6_+_33043703 | 25.13 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
| chr2_+_90060377 | 17.51 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr6_+_32709119 | 15.00 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
| chr12_-_15103621 | 14.55 |
ENST00000536592.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
| chr10_+_5135981 | 13.83 |
ENST00000380554.3
|
AKR1C3
|
aldo-keto reductase family 1, member C3 |
| chr3_-_121379739 | 13.62 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
| chr22_+_23237555 | 12.93 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
| chr1_+_158801095 | 12.47 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
| chr12_+_69742121 | 12.34 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
| chr22_+_23248512 | 12.05 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
| chr2_-_89327228 | 11.86 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr2_-_89385283 | 11.75 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
| chr1_+_117297007 | 11.48 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
| chr2_+_89184868 | 11.04 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
| chr2_-_89619904 | 10.89 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
| chr2_+_89952792 | 10.38 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr4_+_69962212 | 10.18 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr4_-_71532339 | 10.02 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr14_-_106174960 | 9.67 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
| chr4_+_69962185 | 9.60 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr13_-_46756351 | 9.58 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr15_-_20170354 | 9.58 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
| chr4_+_70861647 | 9.48 |
ENST00000246895.4
ENST00000381060.2 |
STATH
|
statherin |
| chr10_-_5060201 | 9.21 |
ENST00000407674.1
|
AKR1C2
|
aldo-keto reductase family 1, member C2 |
| chr5_-_95158644 | 9.20 |
ENST00000237858.6
|
GLRX
|
glutaredoxin (thioltransferase) |
| chr14_-_107114267 | 8.99 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr1_+_198608146 | 8.53 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr13_+_31309645 | 8.02 |
ENST00000380490.3
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein |
| chr1_-_169680745 | 8.01 |
ENST00000236147.4
|
SELL
|
selectin L |
| chr2_+_89999259 | 7.76 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr2_+_90211643 | 7.73 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr10_-_5060147 | 7.67 |
ENST00000604507.1
|
AKR1C2
|
aldo-keto reductase family 1, member C2 |
| chr1_-_158656488 | 7.64 |
ENST00000368147.4
|
SPTA1
|
spectrin, alpha, erythrocytic 1 (elliptocytosis 2) |
| chr11_-_5248294 | 7.54 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
| chr2_-_89278535 | 7.20 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr3_+_122044084 | 7.09 |
ENST00000264474.3
ENST00000479204.1 |
CSTA
|
cystatin A (stefin A) |
| chr13_-_46716969 | 7.08 |
ENST00000435666.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr14_-_106518922 | 7.03 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr14_-_106994333 | 6.91 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
| chr14_-_106963409 | 6.89 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
| chr2_+_89890533 | 6.88 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
| chrX_+_128913906 | 6.87 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
| chr6_-_52628271 | 6.76 |
ENST00000493422.1
|
GSTA2
|
glutathione S-transferase alpha 2 |
| chr6_+_6588316 | 6.61 |
ENST00000379953.2
|
LY86
|
lymphocyte antigen 86 |
| chr2_+_90153696 | 6.61 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
| chr11_+_57365150 | 6.57 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
| chrY_+_2709527 | 6.56 |
ENST00000250784.8
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
| chr14_+_21423611 | 6.56 |
ENST00000304625.2
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
| chr2_-_89247338 | 6.36 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr6_-_49712147 | 6.31 |
ENST00000433368.2
ENST00000354620.4 |
CRISP3
|
cysteine-rich secretory protein 3 |
| chr19_-_54784937 | 6.22 |
ENST00000434421.1
ENST00000314446.5 ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
| chr2_+_89998789 | 6.22 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr5_+_54398463 | 6.15 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
| chr4_+_74275057 | 6.13 |
ENST00000511370.1
|
ALB
|
albumin |
| chr2_+_90458201 | 6.11 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
| chr6_-_25042231 | 6.07 |
ENST00000510784.2
|
FAM65B
|
family with sequence similarity 65, member B |
| chr2_+_89975669 | 5.83 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
| chrX_-_107018969 | 5.80 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr11_-_85376121 | 5.76 |
ENST00000527447.1
|
CREBZF
|
CREB/ATF bZIP transcription factor |
| chr1_-_89591749 | 5.73 |
ENST00000370466.3
|
GBP2
|
guanylate binding protein 2, interferon-inducible |
| chr6_+_32812568 | 5.71 |
ENST00000414474.1
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
| chr17_-_42327236 | 5.70 |
ENST00000399246.2
|
AC003102.1
|
AC003102.1 |
| chr4_+_102734967 | 5.67 |
ENST00000444316.2
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1 |
| chr4_-_100212132 | 5.65 |
ENST00000209668.2
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide |
| chr14_-_106692191 | 5.53 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
| chr14_-_106967788 | 5.47 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr11_+_60223225 | 5.45 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr7_+_150264365 | 5.45 |
ENST00000255945.2
ENST00000461940.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
| chr16_+_33020496 | 5.36 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
| chr1_-_153113927 | 5.29 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
| chr9_-_137809718 | 5.29 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
| chr12_+_51318513 | 5.29 |
ENST00000332160.4
|
METTL7A
|
methyltransferase like 7A |
| chr8_-_134072593 | 5.27 |
ENST00000427060.2
|
SLA
|
Src-like-adaptor |
| chr1_+_26856236 | 5.22 |
ENST00000374168.2
ENST00000374166.4 |
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
| chr10_+_5005445 | 5.11 |
ENST00000380872.4
|
AKR1C1
|
aldo-keto reductase family 1, member C1 |
| chr4_-_70080449 | 5.10 |
ENST00000446444.1
|
UGT2B11
|
UDP glucuronosyltransferase 2 family, polypeptide B11 |
| chr11_-_62752162 | 4.99 |
ENST00000458333.2
ENST00000421062.2 |
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6 |
| chr7_+_50344289 | 4.98 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
| chr4_+_70146217 | 4.95 |
ENST00000335568.5
ENST00000511240.1 |
UGT2B28
|
UDP glucuronosyltransferase 2 family, polypeptide B28 |
| chr9_-_5833027 | 4.84 |
ENST00000339450.5
|
ERMP1
|
endoplasmic reticulum metallopeptidase 1 |
| chr17_-_64216748 | 4.82 |
ENST00000585162.1
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr1_-_207095324 | 4.81 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr10_-_5046042 | 4.74 |
ENST00000421196.3
ENST00000455190.1 |
AKR1C2
|
aldo-keto reductase family 1, member C2 |
| chr21_+_10862622 | 4.71 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
| chr7_+_139528952 | 4.66 |
ENST00000416849.2
ENST00000436047.2 ENST00000414508.2 ENST00000448866.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
| chr14_-_106866934 | 4.62 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
| chr6_-_49712123 | 4.57 |
ENST00000263045.4
|
CRISP3
|
cysteine-rich secretory protein 3 |
| chr2_-_231090344 | 4.51 |
ENST00000540870.1
ENST00000416610.1 |
SP110
|
SP110 nuclear body protein |
| chr12_-_10282836 | 4.51 |
ENST00000304084.8
ENST00000353231.5 ENST00000525605.1 |
CLEC7A
|
C-type lectin domain family 7, member A |
| chr14_-_75593708 | 4.44 |
ENST00000557673.1
ENST00000238616.5 |
NEK9
|
NIMA-related kinase 9 |
| chr1_-_47407136 | 4.44 |
ENST00000462347.1
ENST00000371905.1 ENST00000310638.4 |
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11 |
| chrX_+_123480194 | 4.42 |
ENST00000371139.4
|
SH2D1A
|
SH2 domain containing 1A |
| chr14_-_107078851 | 4.37 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr14_-_106610852 | 4.37 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
| chr1_+_111682058 | 4.37 |
ENST00000545121.1
|
CEPT1
|
choline/ethanolamine phosphotransferase 1 |
| chr12_+_56435637 | 4.36 |
ENST00000356464.5
ENST00000552361.1 |
RPS26
|
ribosomal protein S26 |
| chr7_+_80267973 | 4.35 |
ENST00000394788.3
ENST00000447544.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
| chr4_+_69681710 | 4.34 |
ENST00000265403.7
ENST00000458688.2 |
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
| chr1_+_54359854 | 4.34 |
ENST00000361921.3
ENST00000322679.6 ENST00000532493.1 ENST00000525202.1 ENST00000524406.1 ENST00000388876.3 |
DIO1
|
deiodinase, iodothyronine, type I |
| chr3_+_111260954 | 4.34 |
ENST00000283285.5
|
CD96
|
CD96 molecule |
| chr11_+_63304273 | 4.31 |
ENST00000439013.2
ENST00000255688.3 |
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3 |
| chr8_+_1993152 | 4.29 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
| chr12_-_71533055 | 4.25 |
ENST00000552128.1
|
TSPAN8
|
tetraspanin 8 |
| chr19_-_54876414 | 4.25 |
ENST00000474878.1
ENST00000348231.4 |
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
| chr2_-_89568263 | 4.22 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
| chr14_-_106725723 | 4.20 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr7_+_139529040 | 4.20 |
ENST00000455353.1
ENST00000458722.1 ENST00000411653.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
| chr6_+_31582961 | 4.16 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
| chr12_-_7656357 | 4.16 |
ENST00000396620.3
ENST00000432237.2 ENST00000359156.4 |
CD163
|
CD163 molecule |
| chr1_+_119911425 | 4.13 |
ENST00000361035.4
ENST00000325945.3 |
HAO2
|
hydroxyacid oxidase 2 (long chain) |
| chrY_+_22737678 | 4.06 |
ENST00000382772.3
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
| chr18_+_21693306 | 4.06 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
| chr11_+_65647280 | 4.04 |
ENST00000307886.3
ENST00000528419.1 ENST00000526034.1 |
CTSW
|
cathepsin W |
| chr2_-_89521942 | 4.04 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
| chr2_+_234959323 | 3.99 |
ENST00000373368.1
ENST00000168148.3 |
SPP2
|
secreted phosphoprotein 2, 24kDa |
| chr2_+_8822113 | 3.99 |
ENST00000396290.1
ENST00000331129.3 |
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
| chr6_-_52668605 | 3.97 |
ENST00000334575.5
|
GSTA1
|
glutathione S-transferase alpha 1 |
| chr14_-_106573756 | 3.97 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
| chr21_+_39628852 | 3.88 |
ENST00000398938.2
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
| chr18_+_29171689 | 3.85 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr3_+_186383741 | 3.83 |
ENST00000232003.4
|
HRG
|
histidine-rich glycoprotein |
| chr3_+_186330712 | 3.81 |
ENST00000411641.2
ENST00000273784.5 |
AHSG
|
alpha-2-HS-glycoprotein |
| chr1_+_158978768 | 3.80 |
ENST00000447473.2
|
IFI16
|
interferon, gamma-inducible protein 16 |
| chr5_+_156696362 | 3.77 |
ENST00000377576.3
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr17_-_76124711 | 3.77 |
ENST00000306591.7
ENST00000590602.1 |
TMC6
|
transmembrane channel-like 6 |
| chr1_-_12677714 | 3.76 |
ENST00000376223.2
|
DHRS3
|
dehydrogenase/reductase (SDR family) member 3 |
| chr2_+_203499901 | 3.75 |
ENST00000303116.6
ENST00000392238.2 |
FAM117B
|
family with sequence similarity 117, member B |
| chrX_+_153627231 | 3.74 |
ENST00000406022.2
|
RPL10
|
ribosomal protein L10 |
| chr4_-_100356291 | 3.70 |
ENST00000476959.1
ENST00000482593.1 |
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
| chr11_-_59633951 | 3.69 |
ENST00000257264.3
|
TCN1
|
transcobalamin I (vitamin B12 binding protein, R binder family) |
| chr2_+_231090433 | 3.67 |
ENST00000486687.2
ENST00000350136.5 ENST00000392045.3 ENST00000417495.3 ENST00000343805.6 ENST00000420434.3 |
SP140
|
SP140 nuclear body protein |
| chr14_+_22919081 | 3.66 |
ENST00000390473.1
|
TRDJ1
|
T cell receptor delta joining 1 |
| chr1_+_153004800 | 3.62 |
ENST00000392661.3
|
SPRR1B
|
small proline-rich protein 1B |
| chr22_+_21133469 | 3.61 |
ENST00000406799.1
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
| chr10_+_51576285 | 3.60 |
ENST00000443446.1
|
NCOA4
|
nuclear receptor coactivator 4 |
| chr11_-_6462210 | 3.60 |
ENST00000265983.3
|
HPX
|
hemopexin |
| chr17_-_19648683 | 3.58 |
ENST00000573368.1
ENST00000457500.2 |
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
| chr8_+_27168988 | 3.57 |
ENST00000397501.1
ENST00000338238.4 ENST00000544172.1 |
PTK2B
|
protein tyrosine kinase 2 beta |
| chr4_-_46911248 | 3.57 |
ENST00000355591.3
ENST00000505102.1 |
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
| chr1_+_171217622 | 3.52 |
ENST00000433267.1
ENST00000367750.3 |
FMO1
|
flavin containing monooxygenase 1 |
| chr19_-_10491234 | 3.51 |
ENST00000524462.1
ENST00000531836.1 ENST00000525621.1 |
TYK2
|
tyrosine kinase 2 |
| chr5_+_54320078 | 3.51 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
| chr11_-_57335750 | 3.48 |
ENST00000340573.4
|
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
| chr11_-_114466477 | 3.46 |
ENST00000375478.3
|
NXPE4
|
neurexophilin and PC-esterase domain family, member 4 |
| chr16_+_30211181 | 3.45 |
ENST00000395138.2
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
| chr19_+_42388437 | 3.42 |
ENST00000378152.4
ENST00000337665.4 |
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1 |
| chr9_-_116840728 | 3.41 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
| chr8_+_94241867 | 3.40 |
ENST00000598428.1
|
AC016885.1
|
Uncharacterized protein |
| chr1_+_104198377 | 3.40 |
ENST00000370083.4
|
AMY1A
|
amylase, alpha 1A (salivary) |
| chr3_+_111260856 | 3.39 |
ENST00000352690.4
|
CD96
|
CD96 molecule |
| chr6_+_42584847 | 3.37 |
ENST00000372883.3
|
UBR2
|
ubiquitin protein ligase E3 component n-recognin 2 |
| chrY_+_22737604 | 3.36 |
ENST00000361365.2
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
| chr6_+_131894284 | 3.35 |
ENST00000368087.3
ENST00000356962.2 |
ARG1
|
arginase 1 |
| chr14_-_106878083 | 3.33 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr9_-_116837249 | 3.33 |
ENST00000466610.2
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
| chr2_+_114163945 | 3.29 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
| chr17_+_56315936 | 3.25 |
ENST00000543544.1
|
LPO
|
lactoperoxidase |
| chr14_-_23426322 | 3.25 |
ENST00000555367.1
|
HAUS4
|
HAUS augmin-like complex, subunit 4 |
| chr14_-_23426270 | 3.24 |
ENST00000557591.1
ENST00000397409.4 ENST00000490506.1 ENST00000554406.1 |
HAUS4
|
HAUS augmin-like complex, subunit 4 |
| chr8_+_1993173 | 3.22 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
| chr21_+_39628655 | 3.22 |
ENST00000398925.1
ENST00000398928.1 ENST00000328656.4 ENST00000443341.1 |
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
| chr10_+_73079000 | 3.22 |
ENST00000373189.5
|
SLC29A3
|
solute carrier family 29 (equilibrative nucleoside transporter), member 3 |
| chr11_-_58345569 | 3.21 |
ENST00000528954.1
ENST00000528489.1 |
LPXN
|
leupaxin |
| chr11_-_104817919 | 3.19 |
ENST00000533252.1
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase |
| chr16_+_32077386 | 3.19 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
| chr9_-_123676827 | 3.18 |
ENST00000546084.1
|
TRAF1
|
TNF receptor-associated factor 1 |
| chr13_-_99959641 | 3.17 |
ENST00000376414.4
|
GPR183
|
G protein-coupled receptor 183 |
| chr1_+_6640108 | 3.17 |
ENST00000377674.4
ENST00000488936.1 |
ZBTB48
|
zinc finger and BTB domain containing 48 |
| chr13_-_107220455 | 3.16 |
ENST00000400198.3
|
ARGLU1
|
arginine and glutamate rich 1 |
| chr4_-_48082192 | 3.14 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
| chr1_-_207095212 | 3.13 |
ENST00000420007.2
|
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr5_+_140207536 | 3.13 |
ENST00000529310.1
ENST00000527624.1 |
PCDHA6
|
protocadherin alpha 6 |
| chr6_-_41909561 | 3.07 |
ENST00000372991.4
|
CCND3
|
cyclin D3 |
| chr14_-_23426337 | 3.07 |
ENST00000342454.8
ENST00000555986.1 ENST00000541587.1 ENST00000554516.1 ENST00000347758.2 ENST00000206474.7 ENST00000555040.1 |
HAUS4
|
HAUS augmin-like complex, subunit 4 |
| chr1_-_146054494 | 3.06 |
ENST00000401009.2
|
NBPF11
|
neuroblastoma breakpoint family, member 11 |
| chr7_-_36764004 | 3.05 |
ENST00000431169.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
| chr11_-_57283159 | 3.03 |
ENST00000533263.1
ENST00000278426.3 |
SLC43A1
|
solute carrier family 43 (amino acid system L transporter), member 1 |
| chr7_-_36634181 | 3.02 |
ENST00000538464.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
| chr12_+_10460549 | 3.02 |
ENST00000543420.1
ENST00000543777.1 |
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1 |
| chr22_+_23154239 | 3.01 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
| chr17_-_76124812 | 3.00 |
ENST00000592063.1
ENST00000589271.1 ENST00000322933.4 ENST00000589553.1 |
TMC6
|
transmembrane channel-like 6 |
| chr1_+_43291220 | 3.00 |
ENST00000372514.3
|
ERMAP
|
erythroblast membrane-associated protein (Scianna blood group) |
| chr1_+_90460661 | 2.97 |
ENST00000340281.4
ENST00000361911.5 ENST00000370447.3 ENST00000455342.2 |
ZNF326
|
zinc finger protein 326 |
| chr13_-_99910673 | 2.96 |
ENST00000397473.2
ENST00000397470.2 |
GPR18
|
G protein-coupled receptor 18 |
| chr9_-_95640218 | 2.95 |
ENST00000395506.3
ENST00000375495.3 ENST00000332591.6 |
ZNF484
|
zinc finger protein 484 |
| chr16_+_32063311 | 2.95 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
| chr16_-_67970990 | 2.95 |
ENST00000358514.4
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
| chr17_+_56315787 | 2.95 |
ENST00000262290.4
ENST00000421678.2 |
LPO
|
lactoperoxidase |
| chr2_+_234602305 | 2.94 |
ENST00000406651.1
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6 |
| chr14_+_20937538 | 2.94 |
ENST00000361505.5
ENST00000553591.1 |
PNP
|
purine nucleoside phosphorylase |
| chr4_-_110723194 | 2.93 |
ENST00000394635.3
|
CFI
|
complement factor I |
| chrX_+_153626708 | 2.92 |
ENST00000436473.1
ENST00000344746.4 ENST00000458500.1 |
RPL10
|
ribosomal protein L10 |
| chr2_-_43823119 | 2.92 |
ENST00000403856.1
ENST00000404790.1 ENST00000405975.2 ENST00000415080.2 |
THADA
|
thyroid adenoma associated |
| chr17_-_62084241 | 2.91 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
| chr2_-_43823093 | 2.87 |
ENST00000405006.4
|
THADA
|
thyroid adenoma associated |
| chr12_-_113772835 | 2.84 |
ENST00000552014.1
ENST00000548186.1 ENST00000202831.3 ENST00000549181.1 |
SLC8B1
|
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 |
| chr11_+_116700600 | 2.81 |
ENST00000227667.3
|
APOC3
|
apolipoprotein C-III |
| chr11_+_118175132 | 2.80 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr9_-_95244781 | 2.79 |
ENST00000375544.3
ENST00000375543.1 ENST00000395538.3 ENST00000450139.2 |
ASPN
|
asporin |
Network of associatons between targets according to the STRING database.
First level regulatory network of MAFK
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.0 | 42.2 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 3.6 | 14.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 2.6 | 7.7 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 2.5 | 12.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 2.3 | 2.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 2.3 | 6.8 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 2.0 | 4.0 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
| 1.9 | 7.8 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 1.9 | 11.5 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 1.9 | 7.5 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 1.8 | 5.3 | GO:0060621 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
| 1.8 | 5.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 1.7 | 8.5 | GO:0048539 | immunoglobulin biosynthetic process(GO:0002378) bone marrow development(GO:0048539) |
| 1.7 | 6.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 1.7 | 5.0 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 1.6 | 4.7 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 1.6 | 6.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 1.5 | 1.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 1.5 | 222.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.5 | 4.4 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 1.4 | 5.8 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.2 | 6.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.2 | 3.6 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 1.2 | 9.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 1.2 | 26.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 1.1 | 3.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 1.1 | 5.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 1.1 | 9.5 | GO:0046541 | saliva secretion(GO:0046541) |
| 1.0 | 16.7 | GO:0051639 | actin filament network formation(GO:0051639) |
| 1.0 | 2.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 1.0 | 6.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 1.0 | 12.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 1.0 | 2.9 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) inosine metabolic process(GO:0046102) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 1.0 | 3.8 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.9 | 2.8 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.9 | 2.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.9 | 2.7 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.9 | 0.9 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
| 0.9 | 8.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.9 | 6.2 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 0.9 | 3.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.8 | 4.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 0.8 | 5.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.8 | 3.3 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.8 | 6.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.8 | 4.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) basic amino acid transmembrane transport(GO:1990822) |
| 0.8 | 5.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.8 | 13.6 | GO:0045651 | positive regulation of granulocyte differentiation(GO:0030854) positive regulation of macrophage differentiation(GO:0045651) |
| 0.8 | 2.3 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.7 | 6.7 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.7 | 5.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.7 | 2.2 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.7 | 2.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) cellular amide catabolic process(GO:0043605) |
| 0.7 | 2.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.7 | 2.1 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.7 | 2.1 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) regulation of response to macrophage colony-stimulating factor(GO:1903969) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 0.7 | 6.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.7 | 5.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.7 | 6.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.7 | 3.4 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.7 | 2.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.7 | 3.3 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 0.7 | 2.0 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.6 | 2.6 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.6 | 0.6 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.6 | 0.6 | GO:0016569 | covalent chromatin modification(GO:0016569) |
| 0.6 | 14.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.6 | 3.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.6 | 1.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.6 | 4.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.6 | 1.8 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
| 0.6 | 6.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.6 | 1.8 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.6 | 3.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.6 | 87.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.6 | 1.2 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
| 0.6 | 1.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.6 | 3.4 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.6 | 2.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.5 | 0.5 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
| 0.5 | 3.2 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.5 | 3.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.5 | 8.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.5 | 3.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.5 | 3.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.5 | 2.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.5 | 2.0 | GO:0048807 | ectoderm and mesoderm interaction(GO:0007499) female genitalia morphogenesis(GO:0048807) |
| 0.5 | 3.4 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.5 | 2.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.5 | 2.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 0.5 | 1.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.5 | 3.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.5 | 3.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.5 | 2.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.5 | 0.9 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.5 | 2.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.4 | 5.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.4 | 3.6 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.4 | 1.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.4 | 3.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.4 | 1.7 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.4 | 1.7 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.4 | 7.6 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.4 | 2.5 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.4 | 24.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.4 | 4.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.4 | 3.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 | 2.8 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.4 | 11.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.4 | 40.4 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.4 | 2.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 | 1.2 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
| 0.4 | 2.3 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.4 | 1.5 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.4 | 1.2 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) positive regulation of sarcomere organization(GO:0060298) |
| 0.4 | 4.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.4 | 4.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.4 | 1.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.4 | 3.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 | 0.7 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.4 | 1.1 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.4 | 1.1 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.4 | 3.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.3 | 1.4 | GO:0042320 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) negative regulation of urine volume(GO:0035811) regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
| 0.3 | 2.0 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.3 | 9.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.3 | 3.0 | GO:0015886 | heme transport(GO:0015886) |
| 0.3 | 1.0 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.3 | 6.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.3 | 2.0 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.3 | 1.6 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.3 | 1.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.3 | 2.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.3 | 1.3 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.3 | 1.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.3 | 5.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.3 | 3.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.3 | 0.6 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.3 | 2.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.3 | 0.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.3 | 1.5 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.3 | 4.5 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.3 | 1.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.3 | 10.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.3 | 2.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.3 | 2.5 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.3 | 1.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.3 | 1.1 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.3 | 1.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.3 | 0.8 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.3 | 2.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.3 | 2.7 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 2.1 | GO:0015705 | iodide transport(GO:0015705) |
| 0.3 | 4.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.3 | 1.3 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.3 | 3.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.3 | 7.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.3 | 1.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.3 | 2.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 | 0.8 | GO:1901837 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.2 | 5.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.2 | 4.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.2 | 0.7 | GO:0050917 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
| 0.2 | 0.7 | GO:1904404 | response to vitamin B1(GO:0010266) cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.2 | 1.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.2 | 1.9 | GO:0002252 | immune effector process(GO:0002252) |
| 0.2 | 4.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.2 | 0.7 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.2 | 1.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.2 | 0.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 | 1.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 10.7 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
| 0.2 | 0.4 | GO:0006956 | complement activation(GO:0006956) |
| 0.2 | 9.0 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.2 | 0.8 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.2 | 1.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.2 | 0.4 | GO:0002436 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
| 0.2 | 1.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 | 0.4 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.2 | 2.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 | 1.2 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.2 | 1.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.2 | 2.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 1.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.2 | 1.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 2.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.2 | 1.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.2 | 3.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 | 1.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 | 24.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.2 | 2.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.2 | 1.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.2 | 2.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.2 | 4.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 2.6 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 1.8 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 0.6 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 5.0 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.1 | 0.7 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.1 | 0.4 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.1 | 1.7 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
| 0.1 | 1.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.1 | 2.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 0.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 1.0 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.1 | 0.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.1 | 0.4 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 | 1.4 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 4.8 | GO:0033198 | response to ATP(GO:0033198) |
| 0.1 | 1.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 0.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.1 | 2.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.1 | 1.7 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.1 | 1.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 | 2.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 | 2.3 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 0.9 | GO:0010506 | regulation of autophagy(GO:0010506) |
| 0.1 | 0.7 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 1.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 1.4 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 1.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.1 | 1.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 1.4 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.1 | 0.2 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.1 | 3.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.7 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 | 0.4 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 | 1.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.1 | 2.0 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 0.1 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.1 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) t-circle formation(GO:0090656) |
| 0.1 | 1.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.1 | 5.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 | 1.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.1 | 2.0 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 | 1.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 | 1.3 | GO:0006068 | ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
| 0.1 | 4.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 0.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.4 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
| 0.1 | 1.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 0.3 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.1 | 0.2 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.1 | 1.0 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.1 | 1.9 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.1 | 1.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 3.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.1 | 0.9 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 | 1.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 2.0 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 | 4.2 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.1 | 0.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.1 | 1.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 2.0 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 0.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 4.6 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 7.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.1 | 2.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 0.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.2 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 | 0.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 0.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 | 4.0 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 1.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.1 | 2.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 | 0.7 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 | 1.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 | 1.3 | GO:0001649 | osteoblast differentiation(GO:0001649) |
| 0.1 | 0.3 | GO:1990481 | tRNA pseudouridine synthesis(GO:0031119) mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 | 0.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 0.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.1 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 0.4 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.1 | 2.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 | 0.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.7 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
| 0.1 | 0.8 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.7 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 7.4 | GO:0006413 | translational initiation(GO:0006413) |
| 0.1 | 2.6 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 0.4 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.1 | 0.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
| 0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 5.0 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
| 0.1 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 2.4 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 0.4 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.1 | 1.3 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.1 | 0.9 | GO:0017156 | synaptic vesicle exocytosis(GO:0016079) calcium ion regulated exocytosis(GO:0017156) |
| 0.1 | 0.8 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 1.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.6 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
| 0.0 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 1.2 | GO:0021983 | pituitary gland development(GO:0021983) |
| 0.0 | 1.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.0 | 0.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.0 | 0.9 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.0 | 1.4 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.0 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 | 1.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
| 0.0 | 0.9 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.0 | 1.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 0.0 | 1.7 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
| 0.0 | 1.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.0 | 1.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 | 1.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 1.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.0 | 0.5 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.0 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.3 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 2.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.0 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.0 | 0.9 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.0 | 0.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 1.1 | GO:0001947 | heart looping(GO:0001947) |
| 0.0 | 1.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
| 0.0 | 0.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) citrate metabolic process(GO:0006101) |
| 0.0 | 0.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 | 1.2 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 1.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.0 | 0.6 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.0 | 0.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.0 | 1.3 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.0 | 3.5 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.0 | 0.6 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.0 | 1.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.0 | 0.4 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.0 | 1.4 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
| 0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.0 | 0.2 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 0.0 | 0.7 | GO:0001541 | ovarian follicle development(GO:0001541) |
| 0.0 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.0 | 0.2 | GO:0030239 | myofibril assembly(GO:0030239) |
| 0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.6 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
| 0.0 | 0.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 | 0.8 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.0 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
| 0.0 | 0.8 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.0 | 0.9 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
| 0.0 | 0.4 | GO:0046849 | bone remodeling(GO:0046849) |
| 0.0 | 1.0 | GO:0007586 | digestion(GO:0007586) |
| 0.0 | 0.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.0 | 0.4 | GO:0001895 | retina homeostasis(GO:0001895) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 9.7 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 2.0 | 42.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.9 | 7.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 1.5 | 71.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 1.5 | 4.4 | GO:0061673 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
| 1.1 | 20.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 1.1 | 7.6 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.1 | 8.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 1.1 | 6.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 1.1 | 9.6 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.0 | 3.0 | GO:0044609 | DBIRD complex(GO:0044609) |
| 1.0 | 5.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.9 | 5.3 | GO:0034366 | intermediate-density lipoprotein particle(GO:0034363) spherical high-density lipoprotein particle(GO:0034366) |
| 0.8 | 5.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.8 | 14.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.8 | 134.4 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.6 | 3.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.6 | 1.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.6 | 1.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.6 | 1.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.5 | 13.1 | GO:0032982 | myosin filament(GO:0032982) |
| 0.5 | 2.5 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.5 | 4.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.4 | 41.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.4 | 1.9 | GO:0000801 | central element(GO:0000801) |
| 0.4 | 5.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.3 | 1.7 | GO:0071546 | pi-body(GO:0071546) |
| 0.3 | 3.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.3 | 0.9 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.3 | 4.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.3 | 16.1 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 1.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.3 | 0.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.3 | 4.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.3 | 20.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.3 | 3.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.3 | 1.3 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.3 | 3.6 | GO:0044754 | autolysosome(GO:0044754) |
| 0.3 | 1.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.3 | 2.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.3 | 1.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.2 | 4.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 0.2 | 3.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 3.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 7.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.2 | 1.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.2 | 1.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.2 | 13.5 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.2 | 0.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.2 | 1.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.2 | 2.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.2 | 2.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.2 | 2.0 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.2 | 2.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 0.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 1.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 6.1 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 37.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 0.6 | GO:0000811 | GINS complex(GO:0000811) |
| 0.1 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 14.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 3.5 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 1.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 2.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 0.7 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 5.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 2.2 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.8 | GO:0001740 | Barr body(GO:0001740) |
| 0.1 | 0.9 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 3.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 2.0 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 3.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 1.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 1.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 0.3 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.1 | 1.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 3.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 3.6 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 104.7 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 5.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 2.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.1 | 1.7 | GO:0005861 | troponin complex(GO:0005861) |
| 0.1 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 2.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 2.6 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 0.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.1 | 2.3 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 5.8 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.1 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.0 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.9 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.0 | 1.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.0 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 1.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 1.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 1.7 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.7 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.0 | 0.7 | GO:0031105 | septin complex(GO:0031105) |
| 0.0 | 0.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 1.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 3.5 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 3.0 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 1.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 1.5 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.9 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
| 0.0 | 2.4 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 1.3 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.0 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 5.4 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 0.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 0.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.8 | 40.6 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 3.4 | 10.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 3.0 | 8.9 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 2.8 | 8.5 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 2.7 | 8.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 2.1 | 12.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 1.9 | 7.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 1.7 | 10.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 1.6 | 1.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 1.6 | 6.2 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 1.6 | 6.2 | GO:0019862 | IgA binding(GO:0019862) |
| 1.5 | 4.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 1.5 | 81.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 1.5 | 14.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.3 | 6.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 1.3 | 227.3 | GO:0003823 | antigen binding(GO:0003823) |
| 1.3 | 5.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 1.3 | 6.6 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 1.3 | 4.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 1.3 | 18.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 1.3 | 7.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 1.2 | 3.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 1.2 | 11.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 1.1 | 8.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 1.1 | 6.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 1.1 | 4.4 | GO:0004307 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
| 1.0 | 2.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.9 | 2.7 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.9 | 2.6 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.9 | 33.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.9 | 2.6 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.8 | 3.4 | GO:0016160 | amylase activity(GO:0016160) |
| 0.8 | 2.4 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.8 | 2.3 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.7 | 2.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.7 | 4.3 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.7 | 2.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.7 | 3.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.7 | 2.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.7 | 6.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.7 | 2.0 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.7 | 6.6 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.7 | 3.3 | GO:0070728 | leucine binding(GO:0070728) |
| 0.7 | 2.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.6 | 5.8 | GO:0043426 | MRF binding(GO:0043426) |
| 0.6 | 3.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.6 | 3.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.6 | 5.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.6 | 3.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.6 | 13.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.6 | 3.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.6 | 3.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.6 | 5.7 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.6 | 6.7 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.5 | 1.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.5 | 2.5 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.5 | 1.5 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.5 | 1.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.5 | 6.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.5 | 3.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.5 | 2.4 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.5 | 1.4 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.5 | 2.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.5 | 2.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.5 | 3.2 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.4 | 1.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.4 | 4.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.4 | 8.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.4 | 2.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.4 | 4.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.4 | 1.3 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.4 | 1.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.4 | 5.8 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.4 | 2.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.4 | 2.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.4 | 2.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.4 | 3.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.4 | 2.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.4 | 1.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.4 | 6.1 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.4 | 1.9 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.4 | 3.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.4 | 1.1 | GO:0005549 | odorant binding(GO:0005549) |
| 0.4 | 1.1 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.4 | 1.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.4 | 2.9 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 1.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.4 | 1.5 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.4 | 1.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.4 | 1.8 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.4 | 2.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.4 | 1.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.3 | 0.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.3 | 2.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.3 | 2.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.3 | 25.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.3 | 0.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.3 | 2.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 3.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.3 | 1.7 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.3 | 1.7 | GO:0089720 | caspase binding(GO:0089720) |
| 0.3 | 2.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.3 | 1.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.3 | 5.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.3 | 1.3 | GO:0015087 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.2 | 2.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.2 | 1.0 | GO:0015254 | glycerol channel activity(GO:0015254) urea channel activity(GO:0015265) |
| 0.2 | 1.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 3.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 0.7 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.2 | 2.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.2 | 2.1 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.2 | 3.7 | GO:0019864 | IgG binding(GO:0019864) |
| 0.2 | 1.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.2 | 1.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 3.2 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 3.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 1.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.2 | 0.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.2 | 1.0 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.2 | 1.0 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
| 0.2 | 4.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.2 | 0.6 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.2 | 2.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 0.6 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.2 | 0.6 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.2 | 2.1 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 0.8 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 2.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.2 | 0.5 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.2 | 5.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 4.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 0.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 1.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 2.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 1.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.2 | 4.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 1.0 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.2 | 0.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 3.0 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.2 | 4.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 0.9 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.2 | 1.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.1 | 3.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.4 | GO:0016297 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
| 0.1 | 0.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.1 | 2.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 2.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.1 | 1.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 2.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 3.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 3.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 1.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 0.3 | GO:0004040 | amidase activity(GO:0004040) |
| 0.1 | 3.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 2.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 1.2 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 1.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 1.0 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 4.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.1 | 0.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 2.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 2.5 | GO:0004601 | peroxidase activity(GO:0004601) |
| 0.1 | 4.9 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 2.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 1.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.1 | 11.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 2.5 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.1 | 4.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
| 0.1 | 14.3 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
| 0.1 | 2.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 2.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 6.9 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 21.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.2 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.1 | 0.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 1.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 6.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.1 | 1.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.1 | 1.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.1 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 1.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 0.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 16.2 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 1.3 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 1.1 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 1.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 1.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 6.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 1.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 3.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.1 | 12.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 5.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 5.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 0.2 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.1 | 3.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 5.3 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 3.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.1 | 1.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 0.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 0.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 2.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.1 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 8.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.0 | 1.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 2.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.0 | 1.0 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 0.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 2.9 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.0 | 5.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 1.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.0 | 9.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 1.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.0 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.0 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.0 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 1.4 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.0 | 0.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 1.0 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
| 0.0 | 1.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 1.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 1.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.0 | 0.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 1.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) D1 dopamine receptor binding(GO:0031748) |
| 0.0 | 0.9 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
| 0.0 | 0.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 3.7 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.7 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 1.6 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 1.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 3.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.3 | 9.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 17.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.2 | 2.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 11.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 7.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 1.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.2 | 3.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.2 | 8.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 11.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 2.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 4.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 3.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 2.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 11.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 2.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 6.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 3.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 5.4 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 25.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 17.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 5.8 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 10.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 2.1 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 6.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 6.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 1.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 2.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 6.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 3.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.1 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 3.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 1.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 5.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 3.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 5.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 2.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 2.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 2.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 1.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 2.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 3.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 1.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 4.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 1.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 4.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 53.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 1.7 | 44.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 1.3 | 10.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 1.0 | 1.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.5 | 8.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.5 | 11.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.4 | 34.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.3 | 8.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.3 | 3.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.3 | 19.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.3 | 9.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.3 | 2.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.3 | 3.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 3.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 6.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 18.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 5.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.2 | 3.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.2 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.2 | 4.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 5.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.2 | 2.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.2 | 3.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.2 | 2.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.2 | 17.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 7.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 6.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 6.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 11.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 17.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 4.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 2.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 0.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.2 | 1.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.2 | 8.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 3.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.1 | 2.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 3.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 1.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.1 | 2.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 2.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 4.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 5.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.1 | 2.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 2.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 17.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 9.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 1.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 4.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 2.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 1.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.1 | 2.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 3.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 0.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 0.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 1.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 2.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 0.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 1.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 1.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 1.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.1 | 2.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 1.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 1.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 2.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 2.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.1 | 2.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 2.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 0.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.1 | 1.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 1.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 4.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 3.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.0 | 1.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 0.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 1.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.0 | 5.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.0 | 1.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 2.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 1.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.0 | 1.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |